Related references
Note: Only part of the references are listed.EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Incorporating biomarker research in a real-world setting: Challenges of a prophecy
Shahrokh F. Shariat
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer
D. M. Bolton et al.
WORLD JOURNAL OF UROLOGY (2014)
The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review
Naveen Kachroo et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Long-term oncological and functional results of extraperitoneal laparoscopic radical prostatectomy: one surgical team's experience on 1,600 consecutive cases
Paolo Verze et al.
WORLD JOURNAL OF UROLOGY (2013)
An Immunohistochemical Signature Comprising PTEN, MYC, and Ki67 Predicts Progression in Prostate Cancer Patients Receiving Adjuvant Docetaxel After Prostatectomy
Emmanuel S. Antonarakis et al.
CANCER (2012)
Diagnostic and prognostic molecular biomarkers for prostate cancer
Glen Kristiansen
HISTOPATHOLOGY (2012)
Expression of potential molecular markers in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy
Hideaki Miyake et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer
Tobias Zellweger et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer
Shahrokh F. Shariat et al.
BJU INTERNATIONAL (2008)
Utility of bcl-2, p53, Ki-67, and caveolin-1 immunostaining in the prediction of biochemical failure after radical prostatectomy in a Japanese population
Takahiro Goto et al.
UROLOGY (2008)
Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability
Sven Gunia et al.
WORLD JOURNAL OF UROLOGY (2008)
EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients
Sari Laitinen et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Challenges of cancer biomarker profiling
Karim Bensalah et al.
EUROPEAN UROLOGY (2007)
Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men
Yousuke Shimizu et al.
BJU INTERNATIONAL (2007)
Immunohistochemical expression of Ki-67 antigen, Cox-2 and Bax/Bcl-2 in prostate cancer;: Prognostic value in biopsies and radical prostatectomy specimens
J Rubio et al.
EUROPEAN UROLOGY (2005)
Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population
T Inoue et al.
UROLOGY (2005)
Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era
AV D'Amico et al.
CANCER (2002)
Perineural invasion and MIB-1 positivity in addition to gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer
TJ Sebo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Tissue Microarray sampling strategy for prostate cancer biomarker analysis
MA Rubin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Prognostic value of cell cycle proteins p27kip1 and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer
AN Vis et al.
JOURNAL OF UROLOGY (2000)
Share Paper
